Markets›Health care›TMO

Thermo Fisher Scientific

TMO
675.00
-3.39 (-0.50%)
Closing price for Sep 25, 2026 from Polygon.io

Valuation

Market value249.58B
Enterprise value288.06B
Price to earnings (P/E)36.3
Price to sales5.4
Price to book4.7
Enterprise value to EBITDA31.0
Free cash flow yield2.9%

Profitability (last 12 months)

Revenue46.34B
Net income6.98B
Gross margin0.0%
Operating margin17.6%
Net margin15.1%
Return on equity13.3%
Return on assets6.2%

Growth (last fiscal year, FY 2025)

Revenue growth+3.9%
EPS growth+7.3%

Balance sheet (latest quarter)

Cash and equivalents4.06B
Total debt42.55B
Debt to equity0.81
Current ratio1.55

Per share and dividends

EPS, diluted (last 12 months)18.59
Shares outstanding369.75M
Dividends paid (last 12 months)None

Trading

Price675.00
52-week high682.98
52-week low435.27
1-year price change+46.09%
Average volume (3 months)2.06M
Beta against the S&P 500 (1 year)0.57

Calculated from Thermo Fisher Scientific's SEC filings (latest quarter ending Jun 27, 2026) and the price above. "Last 12 months" adds up the four most recent quarters. Beta compares one year of daily returns with the S&P 500 (SPY). Dividends from Polygon.io or Nasdaq.